Director, Value, Access & Pricing- US Rare Tumors (TGCT)

Director, Value, Access & Pricing (VAP) leads development and execution of market access and pricing strategies to support pimicotinib for TGCT in the U.S. market. Acts as the product-specific market access expert, developing payer value propositions, access tactics, and field-facing resources; collaborates with cross-functional partners (brand marketing, sales, HEOR, medical affairs, patient services, operations) to align strategy and execution. Requires 9+ years of pharma/biotech experience in rare disease or oncology, 5+ years in internal market access, and hands-on experience with rare disease/oncology launches and cross-functional product teams.